COMMUNIQUÉS West-GlobeNewswire

Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
13/09/2019
Company announcement – No. 34/ 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, September 13, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 [...]
Atara Biotherapeutics Reports Early Findings of Potential Efficacy from Phase 1 Study of ATA188 in Patients with Progressive Multiple Sclerosis at ECTRIMS 2019
13/09/2019
Enrollment in the fourth and final planned Phase 1 dose escalation cohort completed ATA188 targets Epstein-Barr Virus (EBV)-infected B cells, believed to play a role in the pathogenesis of multiple sclerosis Conference [...]
Catalyst Pharmaceuticals, Inc. Determines Not to Proceed with Previously Announced Public Offering of Common Stock
13/09/2019
CORAL GABLES, Fla., Sept. 13, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (NasdaqCM: CPRX) today announced that it will not conclude the offering of shares of its common stock announced on Wednesday, [...]
Digirad Announces Listing and Trading of Preferred Stock on Nasdaq Global Market Under Symbol “DRADP”
13/09/2019
SUWANEE, Ga., Sept. 13, 2019 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ: DRAD) (“Digirad” or the “Company”) announced that its newly issued 10.0% Series A Cumulative Perpetual Preferred Stock, with a stated value [...]
Change of Chairman at ALK
13/09/2019
ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF) today announced that Steen Riisgaard, ALK’s Chairman of the Board, has informed the Board of Directors of his intention to step down at the company's next Annual General [...]
Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis
13/09/2019
Post-hoc analysis from a Phase III open-label extension study showed a 42 percent reduction in the risk of PPMS patients needing a wheelchair after 6.5 years of OCREVUS treatment compared with patients who started [...]
Innate Pharma reports first half 2019 financial results and business update
13/09/2019
INNATE PHARMA REPORTS FIRST HALF 2019 FINANCIAL RESULTS AND BUSINESS UPDATE Initiation of multi-cohort IPH4102 Phase II clinical trial (TELLOMAK) Sézary Syndrome cohort designed to be pivotal; preclinical data supports [...]
Innate Pharma présente ses résultats financiers et l’avancée de son portefeuille au premier semestre 2019
13/09/2019
INNATE PHARMA PRÉSENTE SES RÉSULTATS FINANCIERS ET L’AVANCÉE DE SON PORTEFEUILLE AU PREMIER SEMESTRE 2019 Démarrage de l’essai clinique multicohorte de Phase II d’IPH4102 (TELLOMAK) ; La cohorte syndrome de Sézary est [...]
Roche’s fixed-dose subcutaneous combination of Perjeta and Herceptin showed non-inferiority when compared to intravenous formulations for people with HER2-positive breast cancer
13/09/2019
New fixed-dose combination is administered under the skin in just minutes, significantly reducing the time spent receiving treatment Data will be submitted to health authorities around the world, including the US Food [...]
SpringWorks Therapeutics Announces Pricing Of Initial Public Offering
13/09/2019
STAMFORD, Conn., Sept. 12, 2019 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and [...]
Castle Creek Pharmaceutical Holdings to Acquire Fibrocell
12/09/2019
- Total consideration of $ 63.3 million, including repayment of debt and other financial instruments - - Acquisition expected to close in the fourth quarter of 2019 - - Further strengthens Castle Creek Pharmaceuticals [...]
NOTICE TO DISREGARD – Progressive Care Inc.
12/09/2019
MIAMI, Sept. 12, 2019 (GLOBE NEWSWIRE) -- We are advised by Progressive Care, Inc. that journalists and other readers should disregard the news release, Progressive Care Inc. Subsidiaries PharmCo and Family Physicians [...]
Profound Medical Announces Proposed Offerings of Units
12/09/2019
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES TORONTO, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“ Profound ” or the “ Company ”) is pleased to [...]
North Bud Farms Restructures Proposed California Operations with Signing of Offer to Purchase 11-Acre Property in Salinas, California
12/09/2019
TORONTO, Sept. 12, 2019 (GLOBE NEWSWIRE) -- North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) ("NORTHBUD" or the "Company") is pleased to announce that Bonfire Brands USA, a wholly owned subsidiary of NORTHBUD, has [...]
Beyond Air™ to Participate at Two Upcoming Conferences
12/09/2019
GARDEN CITY, N.Y. and REHOVOT, Israel, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) [...]
Ascendis Pharma A/S Announces Presentations on Achondroplasia and TransCon™ CNP at International Skeletal Dysplasia Society Meeting
12/09/2019
– TransCon CNP program gains momentum with initiation of phase 2 ACcomplisH Trial – – Presentations provide new estimate of global birth prevalence and highlight quality-of-life impact of achondroplasia on children and [...]
Ritter Pharmaceuticals Reports Top-Line Results from its Liberatus Phase 3 Trial of RP-G28 for Lactose Intolerance
12/09/2019
LOS ANGELES, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to [...]
SeaSpine to Host Analyst & Investor Event on September 26, 2019
12/09/2019
CARLSBAD, Calif., Sept. 12, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]
Translate Bio Announces Strategic Manufacturing Agreement with AMRI in Support of Messenger RNA (mRNA) Manufacturing
12/09/2019
-- Agreement provides Translate Bio with customized and dedicated manufacturing space for cGMP mRNA production for current and future programs -- LEXINGTON, Mass., Sept. 12, 2019 (GLOBE NEWSWIRE) -- Translate Bio ( [...]

Pages